玻璃酸钠关节腔注射配合中药治疗膝骨性关节炎疗效观察

来源 :中国医疗前沿 | 被引量 : 0次 | 上传用户:yu555497
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨玻璃酸钠关节腔注射配合中药内服治疗膝骨性关节炎效果.方法将120例患者随机分为治疗组和对照组各60例.治疗组采取玻璃酸钠关节腔注射配合中药疗法,对照组采取玻璃酸钠关节腔注射疗法,5周为1疗程.结果治疗组总有效率85.00%,高于对照组的68.33%.结论玻璃酸钠关节腔注射,中药内服治疗能明显改善膝关节功能,疗效优于玻璃酸钠关节腔注射.“,”Objective To evaluate the effectiveness of injecting Sodium Hyaluronate into articular cavity with treatment of traditional Chinese medicine(TCM). Method 120 patients were divided into a treatment group and a contrasting group. In the treatment group, 60 patients received the treatment prescription of injecting Sodium Hyaluronate into articular cavity with treatment of TCM, and in the contrasting group, 60 patients only received the treatment prescription of injecting Sodium Hyaluronate into articular cavity, a period of treatment including 5 weeks. Result In the treatment group, the total effective rate was 85%. In the contrasting group, the total effective rate was 68.33%. Conclusion The result above shows that the treatment prescription of injecting Sodium Hyaluronate into articular cavity with oral administration of TCM may significantly improve the knee function, and this prescription is more effective than that of only injecting Sodium Hyaluronate into articular cavity. Hence it may be concluded that this prescription is an effective treatment of knee osteoarthritis.
其他文献
期刊
目的加强对儿童非霍奇金淋巴瘤临床特点的认识.方法报告以胸腔积液为主要表现入院的儿童非霍奇金淋巴瘤一例,总结经验,减少误诊.结果本例患儿在院外诊断为“肺结核”,抗结核
目的探讨布地奈德混悬液雾化吸入治疗成人急性会厌炎的临床疗效.方法将124例急性会厌炎患者随机分为观察组和对照组各62例,对照组给予常规对症治疗,观察组在此基础上给予布地
国家发展计划委员会副主任王春正,日前在向香港西部访问团介绍西部开发政策时透露,中央将扩大西部地区服务贸易领域利用外商直接投资,允许外资银行在西部经营人民币业务。   
当前,在“走转改”活动取得明显成效的前提下,如何走出特色、走出新意,并使其成为新闻界的常态,成为新闻工作者的自觉行动,是新闻战线面临的一个现实问题。本文紧密结合中央
目的观察吉西他滨(gemcitabine,GEM)联合奈达铂(nedaplatin,NDP)的方案治疗晚期鼻咽癌的近期疗效及毒性反应。方法 21例均为一线含铂方案及二线紫杉类方案化疗失败的晚期鼻咽
目的比较低值血小板患者的血小板进行手工计数法和分析仪计数法的差异.方法分别选取血小板数值
目的多体位观察踝部扭伤患者,更好的显现外踝隐匿性撕脱骨折,减少漏诊率.方法透视下转位观察或改变投照角度发现疑似骨折病例.结果搜集16例踝关节扭伤病例,结合透视观察并摄
目的研究丙氨酸氨基转移酶(ALT)快速检测在血站血液采集前应用的意义.方法以血站血液采集样本作为研究对象,观察组于采集前进行ALT快速检测,统计血液报废率,与上年同期血液采